article thumbnail

Where is the Ignite Theater tech leading us?

Drug Discovery World

For the patient as well as for doctors, this means creating more time to make decisions, as the company believes: “Patients – and their quality of life – shouldn’t have to wait for a broken system to provide an answer six months too late.

article thumbnail

How AI is accelerating the future of precision medicine

Drug Target Review

How does the integration of Real-World Data (RWD) with genomic biomarker data contribute to a more comprehensive understanding of disease progression and treatment response? Biomarker information is also useful for tracking progression of the disease and treatment response. Most drugs do not work in all people.

Doctors 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the researcher: Dr Stephen Jones

Drug Discovery World

Gene editing is a fascinating area of research, as these tools could be used to cure disease or to build models for understanding diseases, but they’re also useful for engineering crops or designing diagnostic tools – there’s such a wide range of applications. DS: What’s been the highlight of your career so far?

Research 147
article thumbnail

Mother of 4-Year-Old Living With KAND, One of the Rarest Disorders in the World, Advocates to Find a Cure

KIF1A

By ANDREA SWINDALL, First Published: 8:34 AM PDT, April 6, 2024 KIF1A Associated Neurological Disorder is a rare severe neurodegenerative disease caused by mutations in the KIF1A gene, Amanda Burrett says. We had her one-year checkup, and the doctor was concerned about her lack of awareness to the environment around her.

Doctors 52
article thumbnail

Medicinal cannabis: Why more clinical trials and better access is needed

Drug Discovery World

There are more than 1300 clinical trials on cannabis underway and companies focused on the cultivation and manufacturing of cannabis are also educating doctors and patients about its potential pharmaceutical use. Meanwhile, the Pfizer purchase of Arena Pharmaceuticals, highlights cannabinoid-based bowel disease treatments as a promising area.

article thumbnail

Finding the North Star of therapeutic antibodies

Drug Discovery World

Nipocalimab, according to Abouzahr, is currently the only FcRn being studied in all three segments of autoantibody-driven disease. She says: “At Janssen, we’re fortunate that we’re building on a leadership that we’ve created over the last couple of decades of treating immune-mediated diseases.

article thumbnail

FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone) for Unclassifiable Interstitial Lung Disease

The Pharma Data

Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and granted Priority Review for Esbriet ® (pirfenidone) for the treatment of unclassifiable interstitial lung disease (UILD). About Unclassifiable Interstitial Lung Disease. Since its U.S. About the Pivotal Study. Indication.

FDA 52